| 1 | [SID26668946] | Active | IC50 | 0.409 | Dose Response selectivity of inhibitors of Striatal-Enriched Phosphatase (STEP) in a SHP2 (PTPN11) Inhibition Assay [AID602367, Type: confirmatory] | tyrosine-protein phosphatase non-receptor type 11 [Homo sapiens] [gi:33356177] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26668946 | | CID | 2953653 | | Outcome | Active | | IC50 | 0.409 [uM] | | BioAssay | Dose Response selectivity of inhibitors of Striatal-Enriched Phosphatase (STEP) in a SHP2 (PTPN11) Inhibition Assay | | AID | 602367 | | BioAssay type | confirmatory | | Target | tyrosine-protein phosphatase non-receptor type 11 [Homo sapiens] [gi:33356177] | | PubMed | | | Data Table |  |
|
| 2 | [SID26668946] | Active | IC50 | 0.409 | Dose Response selectivity of inhibitors of Striatal-Enriched Phosphatase (STEP) in a SHP2 (PTPN11) Inhibition Assay [AID602367, Type: confirmatory] | tyrosine-protein phosphatase non-receptor type 11 [Homo sapiens] [gi:33356177] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 26668946 | | CID | 2953653 | | Outcome | Active | | IC50 | 0.409 [uM] | | BioAssay | Dose Response selectivity of inhibitors of Striatal-Enriched Phosphatase (STEP) in a SHP2 (PTPN11) Inhibition Assay | | AID | 602367 | | BioAssay type | confirmatory | | Target | tyrosine-protein phosphatase non-receptor type 11 [Homo sapiens] [gi:33356177] | | PubMed | | | Data Table |  |
|
| 3 | [SID26668946] | Active | IC50 | 0.716 | Dose Response selectivity of inhibitors of STriatal-Enriched Phosphatase (STEP) in the dual-specificity protein-tyrosine phosphatase VHR Inhibition Assay [AID602374, Type: confirmatory] | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 26668946 | | CID | 2953653 | | Outcome | Active | | IC50 | 0.716 [uM] | | BioAssay | Dose Response selectivity of inhibitors of STriatal-Enriched Phosphatase (STEP) in the dual-specificity protein-tyrosine phosphatase VHR Inhibition Assay | | AID | 602374 | | BioAssay type | confirmatory | | Target | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] | | PubMed | | | Data Table |  |
|
| 4 | [SID26668946] | Active | IC50 | 0.716 | Dose Response selectivity of inhibitors of STriatal-Enriched Phosphatase (STEP) in the dual-specificity protein-tyrosine phosphatase VHR Inhibition Assay [AID602374, Type: confirmatory] | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26668946 | | CID | 2953653 | | Outcome | Active | | IC50 | 0.716 [uM] | | BioAssay | Dose Response selectivity of inhibitors of STriatal-Enriched Phosphatase (STEP) in the dual-specificity protein-tyrosine phosphatase VHR Inhibition Assay | | AID | 602374 | | BioAssay type | confirmatory | | Target | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] | | PubMed | | | Data Table |  |
|
| 5 | [SID4263927] | Active | IC50 | 1.5 | HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target [AID521, Type: confirmatory] | tyrosine-protein phosphatase non-receptor type 7 isoform 2 [Homo sapiens] [gi:18375660] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | IC50 | 1.5 [uM] | | BioAssay | HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target | | AID | 521 | | BioAssay type | confirmatory | | Target | tyrosine-protein phosphatase non-receptor type 7 isoform 2 [Homo sapiens] [gi:18375660] | | PubMed | | | Data Table |  |
|
| 6 | [SID4263927] | Active | IC50 | 1.5 | HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target [AID521, Type: confirmatory] | tyrosine-protein phosphatase non-receptor type 7 isoform 2 [Homo sapiens] [gi:18375660] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | IC50 | 1.5 [uM] | | BioAssay | HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target | | AID | 521 | | BioAssay type | confirmatory | | Target | tyrosine-protein phosphatase non-receptor type 7 isoform 2 [Homo sapiens] [gi:18375660] | | PubMed | | | Data Table |  |
|
| 7 | [SID4263927] | Active | IC50 | 1.5 | HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target [AID521, Type: confirmatory] | tyrosine-protein phosphatase non-receptor type 7 isoform 2 [Homo sapiens] [gi:18375660] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | IC50 | 1.5 [uM] | | BioAssay | HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target | | AID | 521 | | BioAssay type | confirmatory | | Target | tyrosine-protein phosphatase non-receptor type 7 isoform 2 [Homo sapiens] [gi:18375660] | | PubMed | | | Data Table |  |
|
| 8 | [SID4263927] | Active | IC50 | 2.479 | Fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) [AID651680, Type: confirmatory] | ASAP1 gene product [Homo sapiens] [gi:351542238] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | IC50 | 2.479 [uM] | | BioAssay | Fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) | | AID | 651680 | | BioAssay type | confirmatory | | Target | ASAP1 gene product [Homo sapiens] [gi:351542238] | | PubMed | | | Data Table |  |
|
| 9 | [SID4263927] | Active | Potency | 15.8489 | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 [AID893, Type: confirmatory] | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 | | AID | 893 | | BioAssay type | confirmatory | | Target | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] | | PubMed | | | Data Table |  |
|
| 10 | [SID26668946] | Active | Potency | 16.3601 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26668946 | | CID | 2953653 | | Outcome | Active | | Potency | 16.3601 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID4263927] | Active | | | HIV-1 RT-RNase H MLSCN HTS MH077605 [AID565, Type: screening] | Chain A, Hiv-1 Reverse Transcriptase Mol_id: 1; Molecule: Hiv-1 Reverse Transcriptase; Chain: A, B; [gi:1431733] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | HIV-1 RT-RNase H MLSCN HTS MH077605 | | AID | 565 | | BioAssay type | screening | | Target | Chain A, Hiv-1 Reverse Transcriptase Mol_id: 1; Molecule: Hiv-1 Reverse Transcriptase; Chain: A, B; [gi:1431733] | | PubMed | | | Data Table |  |
|
| 12 | [SID4263927] | Active | | | MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity [AID651723, Type: screening] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity | | AID | 651723 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID4263927] | Active | | | Profiling the NIH Molecular Libraries Small Molecule Repository: Autofluorescence at 339/460 nm [AID709, Type: screening] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | Profiling the NIH Molecular Libraries Small Molecule Repository: Autofluorescence at 339/460 nm | | AID | 709 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID4263927] | Active | | | qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region [AID589, Type: other] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region | | AID | 589 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID4263927] | Active | | | qHTS Assay for Spectroscopic Profiling in A350 Spectral Region [AID590, Type: other] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | qHTS Assay for Spectroscopic Profiling in A350 Spectral Region | | AID | 590 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID4263927] | Active | | | qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region [AID593, Type: other] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region | | AID | 593 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID4263927] | Active | | | Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen [AID598, Type: screening] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen | | AID | 598 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID4263927] | Active | | | 384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC [AID463187, Type: screening] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | 384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC | | AID | 463187 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID4263927] | Active | | | Human Endothelial Cell Proliferation Assay in 384-well format [AID648, Type: screening] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | Human Endothelial Cell Proliferation Assay in 384-well format | | AID | 648 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID4263927] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 21 | [SID4263927] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 22 | [SID4263927] | Active | | | HTS of Estrogen Receptor- alpha Coactivator Binding inhibitors [AID629, Type: screening] | Estrogen receptor 1 [Homo sapiens] [gi:118764400] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | HTS of Estrogen Receptor- alpha Coactivator Binding inhibitors | | AID | 629 | | BioAssay type | screening | | Target | Estrogen receptor 1 [Homo sapiens] [gi:118764400] | | PubMed | | | Data Table |  |
|
| 23 | [SID4263927] | Active | | | HTS of Estrogen Receptor- alpha Coactivator Binding inhibitors [AID629, Type: screening] | Estrogen receptor 1 [Homo sapiens] [gi:118764400] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | HTS of Estrogen Receptor- alpha Coactivator Binding inhibitors | | AID | 629 | | BioAssay type | screening | | Target | Estrogen receptor 1 [Homo sapiens] [gi:118764400] | | PubMed | | | Data Table |  |
|
| 24 | [SID4263927] | Active | | | HTS of Estrogen Receptor- alpha Coactivator Binding inhibitors [AID629, Type: screening] | Estrogen receptor 1 [Homo sapiens] [gi:118764400] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | HTS of Estrogen Receptor- alpha Coactivator Binding inhibitors | | AID | 629 | | BioAssay type | screening | | Target | Estrogen receptor 1 [Homo sapiens] [gi:118764400] | | PubMed | | | Data Table |  |
|
| 25 | [SID4263927] | Active | | | HTS of Estrogen Receptor- alpha Coactivator Binding inhibitors [AID629, Type: screening] | Estrogen receptor 1 [Homo sapiens] [gi:118764400] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | HTS of Estrogen Receptor- alpha Coactivator Binding inhibitors | | AID | 629 | | BioAssay type | screening | | Target | Estrogen receptor 1 [Homo sapiens] [gi:118764400] | | PubMed | | | Data Table |  |
|
| 26 | [SID4263927] | Active | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 27 | [SID4263927] | Active | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 28 | [SID4263927] | Active | | | Primary biochemical high-throughput screening assay for inhibitors of Focal Adhesion Kinase (FAK) [AID727, Type: screening] | Focal adhesion kinase 1 [gi:3183518] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | Primary biochemical high-throughput screening assay for inhibitors of Focal Adhesion Kinase (FAK) | | AID | 727 | | BioAssay type | screening | | Target | Focal adhesion kinase 1 [gi:3183518] | | PubMed | | | Data Table |  |
|
| 29 | [SID4263927] | Active | | | Primary biochemical high-throughput screening assay for inhibitors of Focal Adhesion Kinase (FAK) [AID727, Type: screening] | Focal adhesion kinase 1 [gi:3183518] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | Primary biochemical high-throughput screening assay for inhibitors of Focal Adhesion Kinase (FAK) | | AID | 727 | | BioAssay type | screening | | Target | Focal adhesion kinase 1 [gi:3183518] | | PubMed | | | Data Table |  |
|
| 30 | [SID26668946] | Active | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype [AID1529, Type: screening] | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26668946 | | CID | 2953653 | | Outcome | Active | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype | | AID | 1529 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] | | PubMed | | | Data Table |  |
|
| 31 | [SID26668946] | Active | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype [AID1529, Type: screening] | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26668946 | | CID | 2953653 | | Outcome | Active | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype | | AID | 1529 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] | | PubMed | | | Data Table |  |
|
| 32 | [SID26668946] | Active | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype [AID1529, Type: screening] | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26668946 | | CID | 2953653 | | Outcome | Active | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype | | AID | 1529 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] | | PubMed | | | Data Table |  |
|
| 33 | [SID4263927] | Active | | | Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma) [AID631, Type: screening] | peroxisome proliferator-activated receptor gamma isoform 2 [Homo sapiens] [gi:20336229] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma) | | AID | 631 | | BioAssay type | screening | | Target | peroxisome proliferator-activated receptor gamma isoform 2 [Homo sapiens] [gi:20336229] | | PubMed | | | Data Table |  |
|
| 34 | [SID4263927] | Active | | | Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma) [AID631, Type: screening] | peroxisome proliferator-activated receptor gamma isoform 2 [Homo sapiens] [gi:20336229] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma) | | AID | 631 | | BioAssay type | screening | | Target | peroxisome proliferator-activated receptor gamma isoform 2 [Homo sapiens] [gi:20336229] | | PubMed | | | Data Table |  |
|
| 35 | [SID4263927] | Active | | | Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma) [AID631, Type: screening] | peroxisome proliferator-activated receptor gamma isoform 2 [Homo sapiens] [gi:20336229] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma) | | AID | 631 | | BioAssay type | screening | | Target | peroxisome proliferator-activated receptor gamma isoform 2 [Homo sapiens] [gi:20336229] | | PubMed | | | Data Table |  |
|
| 36 | [SID4263927] | Active | | | Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma) [AID631, Type: screening] | peroxisome proliferator-activated receptor gamma isoform 2 [Homo sapiens] [gi:20336229] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma) | | AID | 631 | | BioAssay type | screening | | Target | peroxisome proliferator-activated receptor gamma isoform 2 [Homo sapiens] [gi:20336229] | | PubMed | | | Data Table |  |
|
| 37 | [SID4263927] | Active | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) [AID624377, Type: screening] | ASAP1 gene product [Homo sapiens] [gi:351542238] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) | | AID | 624377 | | BioAssay type | screening | | Target | ASAP1 gene product [Homo sapiens] [gi:351542238] | | PubMed | | | Data Table |  |
|
| 38 | [SID4263927] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) [AID624431, Type: screening] | ASAP1 gene product [Homo sapiens] [gi:351542238] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1) | | AID | 624431 | | BioAssay type | screening | | Target | ASAP1 gene product [Homo sapiens] [gi:351542238] | | PubMed | | | Data Table |  |
|
| 39 | [SID4263927] | Active | | | LYP Inhibitors-an Autoimmunity Target - Primary screen [AID640, Type: screening] | PTPN22 gene product [Homo sapiens] [gi:224586929] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | LYP Inhibitors-an Autoimmunity Target - Primary screen | | AID | 640 | | BioAssay type | screening | | Target | PTPN22 gene product [Homo sapiens] [gi:224586929] | | PubMed | | | Data Table |  |
|
| 40 | [SID4263927] | Active | | | LYP Inhibitors-an Autoimmunity Target - Primary screen [AID640, Type: screening] | PTPN22 gene product [Homo sapiens] [gi:224586929] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | LYP Inhibitors-an Autoimmunity Target - Primary screen | | AID | 640 | | BioAssay type | screening | | Target | PTPN22 gene product [Homo sapiens] [gi:224586929] | | PubMed | | | Data Table |  |
|
| 41 | [SID4263927] | Active | | | LYP Inhibitors-an Autoimmunity Target - Primary screen [AID640, Type: screening] | PTPN22 gene product [Homo sapiens] [gi:224586929] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | LYP Inhibitors-an Autoimmunity Target - Primary screen | | AID | 640 | | BioAssay type | screening | | Target | PTPN22 gene product [Homo sapiens] [gi:224586929] | | PubMed | | | Data Table |  |
|
| 42 | [SID4263927] | Active | | | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay [AID588621, Type: screening] | PTPN5 gene product [Homo sapiens] [gi:90652859] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay | | AID | 588621 | | BioAssay type | screening | | Target | PTPN5 gene product [Homo sapiens] [gi:90652859] | | PubMed | | | Data Table |  |
|
| 43 | [SID4263927] | Active | | | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay [AID588621, Type: screening] | PTPN5 gene product [Homo sapiens] [gi:90652859] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay | | AID | 588621 | | BioAssay type | screening | | Target | PTPN5 gene product [Homo sapiens] [gi:90652859] | | PubMed | | | Data Table |  |
|
| 44 | [SID26668946] | Active | | | Single concentration confirmation molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay [AID623866, Type: screening] | PTPN5 gene product [Homo sapiens] [gi:90652859] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26668946 | | CID | 2953653 | | Outcome | Active | | BioAssay | Single concentration confirmation molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay | | AID | 623866 | | BioAssay type | screening | | Target | PTPN5 gene product [Homo sapiens] [gi:90652859] | | PubMed | | | Data Table |  |
|
| 45 | [SID26668946] | Active | | | Single concentration confirmation molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay [AID623866, Type: screening] | PTPN5 gene product [Homo sapiens] [gi:90652859] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26668946 | | CID | 2953653 | | Outcome | Active | | BioAssay | Single concentration confirmation molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay | | AID | 623866 | | BioAssay type | screening | | Target | PTPN5 gene product [Homo sapiens] [gi:90652859] | | PubMed | | | Data Table |  |
|
| 46 | [SID4263927] | Active | | | Single concentration validation of uHTS RPN11 inhibitor hits using a Thrombin Fluorescence Polarization assay [AID602333, Type: screening] | prothrombin [Bos taurus] [gi:296479639] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | Single concentration validation of uHTS RPN11 inhibitor hits using a Thrombin Fluorescence Polarization assay | | AID | 602333 | | BioAssay type | screening | | Target | prothrombin [Bos taurus] [gi:296479639] | | PubMed | | | Data Table |  |
|
| 47 | [SID4263927] | Active | | | Single concentration validation of uHTS RPN11 inhibitor hits using a Thrombin Fluorescence Polarization assay [AID602333, Type: screening] | prothrombin [Bos taurus] [gi:296479639] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | Single concentration validation of uHTS RPN11 inhibitor hits using a Thrombin Fluorescence Polarization assay | | AID | 602333 | | BioAssay type | screening | | Target | prothrombin [Bos taurus] [gi:296479639] | | PubMed | | | Data Table |  |
|
| 48 | [SID4263927] | Active | | | uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay [AID588493, Type: screening] | PSMD14 protein [Homo sapiens] [gi:16306916] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Active | | BioAssay | uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay | | AID | 588493 | | BioAssay type | screening | | Target | PSMD14 protein [Homo sapiens] [gi:16306916] | | PubMed | | | Data Table |  |
|
| 49 | [SID4263927] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 50 | [SID4263927] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 4263927 | | CID | 2953653 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|